Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects

NCT03110276 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: EYP001a
DRUG: Placebo

Sponsor

Enyo Pharma

Collaborators

[object Object]